IsoniazidRifampinAntitubercular AgentsAntibiotics, AntitubercularMycobacterium tuberculosisEthambutolPyrazinamideTuberculosis, Multidrug-ResistantTuberculosisTuberculosis, PulmonaryMicrobial Sensitivity TestsEthionamideStreptomycinDrug Resistance, BacterialAminosalicylic AcidDrug Therapy, CombinationDrug Resistance, Multiple, BacterialAminosalicylic AcidsRifamycinsAnti-Bacterial AgentsDrug Resistance, MicrobialCatalaseMycobacteriophagesIsonicotinic AcidsMycobacterium smegmatisClofazimineDrug InteractionsBacterial ProteinsMycobacteriumRifabutinSputumColony Count, MicrobialLatent TuberculosisAza CompoundsTuberculosis, MiliaryDNA-Directed RNA PolymerasesThioacetazoneMycolic AcidsLeprostatic AgentsCytochrome P-450 CYP3AMycobacterium Infections, NontuberculousTuberculosis, Lymph NodeTuberculin TestExtensively Drug-Resistant TuberculosisDrug-Induced Liver InjuryOxidoreductasesDNA, BacterialOfloxacinQuinolinesReceptors, SteroidArylamine N-AcetyltransferaseMutationEnzyme InductionDirectly Observed TherapyTuberculosis, OsteoarticularHydrazinesSouth AfricaTime FactorsMycobacterium kansasiiArea Under CurveNitrate ReductaseCytochrome P-450 CYP2E1